China and America's Drug Supply: A Looming Crisis
John Solomon Reports
00:00
Reevaluating Pharmaceutical Manufacturing
This chapter examines the shift of prescription drug manufacturing to overseas markets and the legislative measures needed to promote onshoring in the U.S. It highlights the vulnerabilities in the pharmaceutical supply chain, particularly dependence on China, and discusses the importance of strategic initiatives to ensure a stable and secure drug supply.
Transcript
Play full episode
